Пациентите, лекувани с Trudexa, получиха на 12- та седмица статистически значимо р
Trudexa treated patients had significantly greater improvement at Week 12 which was maintained through Week 24 in both the SF36 and Ankylosing Spondylitis Quality of Life Questionnaire